The DOI matches its Crossref record; 351 of the 351 references it cites were found in a registry or an index.
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Open accessAbstract
Despite the success of renin-angiotensin system (RAS) blockade by angiotensin-converting enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT 1 R) blockers, current therapies for hypertension and related cardiovascular diseases are still inadequate.Identification of additional components of the RAS and associated vasoactive pathways, as well as new structural and functional insights into established targets, have led to novel therapeutic approaches with the potential to provide improved cardiovascular protection and better blood pressure control and/or reduced adverse side effects.The simultaneous modulation of several neurohumoral mediators in key interconnected blood pressure-regulating pathways has been an attractive approach to improve treatment efficacy, and several novel approaches involve combination therapy or dualacting agents.In addition, increased understanding of the complexity of the RAS has led to novel approaches aimed at upregulating the ACE2/angiotensin-(1-7)/Mas axis to counter-regulate the harmful effects of the ACE/angiotensin II/angiotensin III/AT 1 R axis.These advances have opened new avenues for the development of novel drugs targeting the RAS to better treat hypertension and heart failure.Here we focus on new therapies in preclinical and early clinical stages of development, including novel small molecule inhibitors and receptor agonists/ antagonists, less conventional strategies such as gene therapy to suppress angiotensinogen at the RNA level, recombinant ACE2 protein, and novel bispecific designer peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–351 of 351
Angiotensin 1–9 and 1–7 release in human heart role of cathepsin, A
Jackman, H. L., Massad, M. G., Sekosan, M., Tan, F., Brovkovych, V., Marcic, B. M., & Erdös, E. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000017283.67962.02 · Cited by 110
Omapatrilat—the story of Overture and Octave
Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00389-3 · Cited by 107 · cited 2×
“To further study the efficacy and safety of omapatrilat, large randomized clinical trials were undertaken to assess the efficacy and safety profile of omapatrilat in patients with hypertension and heart failure, compared with the conventional ACE inhibitor enalapril (Coats, 2002) .”
Flores‐Muñoz, M., Work, L. M., Douglas, K. B., Denby, L., Dominiczak, A. F., Graham, D., & Nicklin, S. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.177485 · Cited by 107
Hinder, L. M., Vivekanandan‐Giri, A., McLean, L. L., Pennathur, S., & Feldman, E. L. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0356 · Cited by 107
The kallikrein-kinin system in health and in diseases of the kidney
Kakoki, M., & Smithies, O. (2009) · Kidney International · doi:10.1038/ki.2008.647 · Cited by 106 · cited 1×
“1) (Regoli and Barabé, 1980; Kakoki and Smithies, 2009).”
Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin
Hoang, M. V., & Turner, A. J. (1997) · Biochemical Journal · doi:10.1042/bj3270023 · Cited by 106
Vazeux, G., Wang, J. O., Corvol, P. L., & Llorens‐Cortés, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9069 · Cited by 106
Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure
Bodineau, L., Frugière, A., Marc, Y., Inguimbert, N., Fassot, C., Balavoine, F., Roques, B. P., & Llorens‐Cortés, C. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.098772 · Cited by 106
Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat
Wielbo, D., Sernia, C., Gyurko, R., & Phillips, M. I. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.314 · Cited by 105
Tom, B., VRIES, R. D., Saxena, P. R., & Danser, A. H. J. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.95 · Cited by 105
Self-citationCharles, C. J., Espiner, E. A., Nicholls, M. G., et al. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.2.r373 · Cited by 105
Komers, R., & Plotkin, H. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00425.2015 · Cited by 105
Processing of proendothelin‐1 by human furin convertase
Denault, J., Claing, A., D’Orléans-Juste, P., Sawamura, T., Kido, T., Masaki, Τ., & Leduc, R. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00249-9 · Cited by 104
Fuchs, S., Xiao, H., Cole, J. M., Adams, J. W., Frenzel, K. E., Michaud, A., Zhao, H., Keshelava, G., Capecchi, M. R., Corvol, P. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400149200 · Cited by 104
Karnik, S. S., Singh, K. D., Tirupula, K. C., & Ünal, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13742 · Cited by 104
Kuoppala, A., Lindstedt, K. A., Saarinen, J., Kovanen, P. T., & Kokkonen, J. O. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1069 · Cited by 103
Fonarow, G. C., Hernandez, A. F., Solomon, S. D., & Yancy, C. W. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1724 · Cited by 103
Macheret, F., Heublein, D. M., Costello‐Boerrigter, L. C., Boerrigter, G., McKie, P. M., Bellavia, D., Mangiafico, S., Ikeda, Y., Bailey, K. R., Scott, C. G., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.049 · Cited by 102
Self-citationEffect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema
Straka, B. T., Ramirez, C. E., Byrd, J. B., Stone, E., Woodard‐Grice, A. V., Nian, H., Yu, C., Banerji, A., & Brown, N. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.051 · Cited by 102
Flores‐Muñoz, M., Smith, N. J., Haggerty, C., Milligan, G., & Nicklin, S. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.203075 · Cited by 101
Ocaranza, M. P., Moya, J., Barrientos, V., Alzamora, R., Hevia, D., Morales, C., Pinto, M., Escudero, N., Garcı́a, L., Novoa, U., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000094 · Cited by 100
Lojda, Z., & Gossrau, R. (1980) · Histochemistry · doi:10.1007/bf00692761 · Cited by 99
Corradi, H. R., Chitapi, I., Sewell, B. T., Georgiadis, D., Dive, V., Sturrock, E. D., & Acharya, K. R. (2007) · Biochemistry · doi:10.1021/bi700275e · Cited by 99
Self-citationWeber, M. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06584-9 · Cited by 98
Simon, S. R. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400200128023 · Cited by 97
Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro
Ocaranza, M. P., Lavandero, S., Jalil, J., Moya, J., Pinto, M., Novoa, U., Apablaza, F., González, L., Hernández, C., Varas‐Godoy, M., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328335d291 · Cited by 96
Novel Protein Therapeutics for Systolic Heart Failure
Chen, H. H., Glockner, J. F., Schirger, J. A., Cataliotti, A., Redfield, M. M., & Burnett, J. C. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.056 · Cited by 95
Self-citationConversion of brain angiotensin II to angiotensin III is critical for pressor response in rats
Wright, J. W., Tamura-Myers, E., Wilson, W. L., Roques, B. P., Llorens‐Cortés, C., Speth, R. C., & Harding, J. W. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00326.2002 · Cited by 95
Danser, A. H. J., Derkx, F. H. M., Hense, H. W., Jeunemaître, X., Riegger, G. A. J., & Schunkert, H. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00005 · Cited by 94
Self-citationVodovar, N., Seronde, M., Laribi, S., Gayat, É., Lassus, J. P. E., Januzzi, J. L., Boukef, R., Nouira, S., Manivet, P., Samuel, J., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.03.011 · Cited by 93
Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)
Bernstein, K. E., Shen, X. Z., González-Villalobos, R. A., Billet, S., Okwan-Duodu, D. K., Ong, F. S.-C., & Fuchs, S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.11.001 · Cited by 93
Llorens‐Cortés, C., Gacel, G., Swerts, J.-P., Perdrisot, R., Fournié‐Zaluski, M., Schwartz, J.-C., & Roques, B. P. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91371-6 · Cited by 93
Murugesan, N., Gu, Z., Fadnis, L., Tellew, J. E., Baska, R. A. F., Yang, Y., Beyer, S. M., Monshizadegan, H., Dickinson, K. E. J., Valentine, M. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049548x · Cited by 91
Angiotensin metabolites can stimulate receptors of the Mas-related genes family
Gembardt, F., Grajewski, S., Vahl, M., Schultheiss, H., & Walther, T. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9884-4 · Cited by 90
Junot, C., Gonzales, M.-F., Ezan, É., Cotton, J., Vazeux, G., Michaud, A., Azizi, M., Vassiliou, S., Yiotakis, A., Corvol, P. L., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29576-8 · Cited by 90
Cataliotti, A., Tonne, J. M., Bellavia, D., Martín, F. L., Oehler, E. A., Harders, G. E., Campbell, J. M., Peng, K.-W., Russell, S. J., Malatino, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.981720 · Cited by 89
Self-citationAngioedema: the role of ACE inhibitors and factors associated with poor clinical outcome
Agah, R., Bandi, V., & Guntupalli, K. K. (1997) · Intensive Care Medicine · doi:10.1007/s001340050413 · Cited by 87
Angiotensin-converting Enzyme Inhibitors as Inducers of Adverse Cutaneous Reactions
Steckelings, U. M. (2001) · Acta Dermato Venereologica · doi:10.1080/000155501317140007 · Cited by 86
Brain Renin–Angiotensin System
van Thiel, B. S., Martini, A. G., Riet, L. T., Severs, D., Uijl, E., Garrelds, I. M., Leijten, F. P. J., van der Pluijm, I., Essers, J., Qadri, F., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08922 · Cited by 86
Self-citationDiscovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors
Shemesh, R., Toporik, A., Levine, Z., Hecht, I., Rotman, G., Wool, A., Dahary, D., Gofer, E., Kliger, Y., Ayalon-Soffer, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805181200 · Cited by 85
Mogensen, U. M., Gong, J., Jhund, P. S., Shen, L., Køber, L., Desai, A. S., Lefkowitz, M. P., Packer, M., Rouleau, J. L., Solomon, S. D., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1139 · Cited by 84
Ohshima, K., Mogi, M., Nakaoka, H., Iwanami, J., Min, L., Kan‐no, H., Tsukuda, K., Chisaka, T., Bai, H., Wang, X., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02426 · Cited by 83
A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A
Vazeux, G., Iturrioz, X., Corvol, P. L., & Llorens‐Cortés, C. (1998) · Biochemical Journal · doi:10.1042/bj3340407 · Cited by 83
Structural analysis of neprilysin with various specific and potent inhibitors
Oefner, C., Roques, B. P., Fournie-Zaluski, M.-C., & Dale, G. E. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903027410 · Cited by 81
Torrado, J., Cain, C. K., Mauro, A. G., Romeo, F. J., Ockaili, R. A., Chau, V. Q., Nestler, J. A., Devarakonda, T., Ghosh, S., Das, A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.102 · Cited by 81
ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts
Grobe, J. L., Sarkissian, S. D., Stewart, J. M., Meszaros, J. G., Raizada, M. K., & Katovich, M. J. (2007) · Clinical Science · doi:10.1042/cs20070160 · Cited by 80
Healy, D. P., & Wilk, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90997-2 · Cited by 80
Hansen, J. L., Theilade, J., Haunsø, S., & Sheikh, S. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400092200 · Cited by 79
Marc, Y., Gao, J., Balavoine, F., Michaud, A., Roques, B. P., & Llorens‐Cortés, C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.190942 · Cited by 79
Morrow, D. A., Velazquez, E. J., DeVore, A. D., PRESCOTT, M. F., Duffy, C. I., Gurmu, Y., McCague, K., Rocha, R., & D, E. B. M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz240 · Cited by 79
Mullick, A. E., Yeh, S. T., Graham, M. J., Engelhardt, J. A., Prakash, T. P., & Crooke, R. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09755 · Cited by 77
Woodman, Z., Oppong, S. Y., Sarah, C. O. O. K., Hooper, N. M., Schwager, S. L. U., BRANDT, W. F., Ehlers, M. R., & Sturrock, E. D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470711 · Cited by 76
Self-citationDanser, A. H. J., Batenburg, W. W., van den Meiracker, A. H., & Danilov, S. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.12.001 · Cited by 73
Self-citationThan, A., Leow, M. K., & Chen, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.459792 · Cited by 73
Yu, L., Yuan, K., Phuong, H. T. A., Park, B. M., & Kim, S. H. (2016) · Peptides · doi:10.1016/j.peptides.2016.09.009 · Cited by 73
Structure of neprilysin in complex with the active metabolite of sacubitril
Schiering, N., D'Arcy, A., Villard, F., Ramage, P., Logel, C., Cumin, F., Ksander, G. M., Wiesmann, C., Karki, R. G., & Mogi, M. (2016) · Scientific Reports · doi:10.1038/srep27909 · Cited by 72
Identification of two active site residues in human angiotensin I-converting enzyme.
Williams, T. A., Corvol, P. L., & Soubrier, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43897-5 · Cited by 70
Multiple Growth Factors Modulate mRNA Expression of Angiotensin II Type-2 Receptor in R3T3 Cells
Ichiki, T., Kambayashi, Y., & Inagami, T. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1070 · Cited by 69
Ehlers, M. R., Schwager, S. L. U., Scholle, R. R., Manji, G. A., BRANDT, W. F., & Riordan, J. F. (1996) · Biochemistry · doi:10.1021/bi9602425 · Cited by 69
Self-citationHistidine residue in the zinc-binding motif of aminopeptidase A is critical for enzymatic activity.
Wang, J., & COOPER, M. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1222 · Cited by 69
Matsusaka, T., Niimura, F., Pastan, I. H., Shintani, A., Nishiyama, A., & Ichikawa, I. (2013) · Kidney International · doi:10.1038/ki.2013.453 · Cited by 67
Intengan, H. D., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1221 · Cited by 66
Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events
Pinter, M., Kwanten, W. J., & Jain, R. K. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0236 · Cited by 64
Kambayashi, Y., Nagata, K., Ichiki, T., & Inagami, T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0558u.x · Cited by 62
Ambroz, C., Clark, A. J. L., & Catt, K. J. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90248-v · Cited by 61
Fagyas, M., Katalin, Ú., Siket, I. M., Fülöp, G. Á., Csató, V., Daragó, A., Boczán, J., Bányai, E., Szentkirályi, I., Maros, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087844 · Cited by 61
The role of angiotensin‐(1–7) receptor Mas in spermatogenesis in mice and rats
Leal, M. C., Pinheiro, S. V. B., Ferreira, A. J., Santos, R. A. S., Bordoni, L. S., Alenina, N. V., Bäder, M., & França, L. R. (2009) · Journal of Anatomy · doi:10.1111/j.1469-7580.2009.01058.x · Cited by 61
Developmental changes in AT1 and AT2 receptor-protein expression in rats
Li, Y., Zheng, M., Wang, W., Rozanski, G. J., Zucker, I. H., & Gao, L. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310379065 · Cited by 61
Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J., & Scholey, J. W. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00455.2011 · Cited by 61
Gaidarov, I., Adams, J. W., Frazer, J. M., Anthony, T. L., Chen, X., Gatlin, J., Semple, G., & Unett, D. J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.06.007 · Cited by 61
Watermeyer, J. M., Kröger, W. L., O’Neill, H. G., Sewell, B. T., & Sturrock, E. D. (2008) · Biochemistry · doi:10.1021/bi8002605 · Cited by 60
Self-citationAngiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema
Stone, C. A., & Brown, N. J. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.04.006 · Cited by 60
Kompa, A. R., Lu, J., Weller, T. J., Kelly, D. J., Krum, H., von Lueder, T. G., & Wang, B. H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.077 · Cited by 60
Ren, L., Sun, Y., Lu, H., Ye, D., Han, L., Wang, N., Daugherty, A., Li, F., Wang, M., Su, F., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312422 · Cited by 59
Self-citationRøsjø, H. R., Dahl, M. B., Jørgensen, M. E., Røysland, R., Brynildsen, J., Cataliotti, A., Christensen, G., Høiseth, A. D., Hagve, T., & Omland, T. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239673 · Cited by 59
Balavoine, F., Azizi, M., Bergerot, D., Mota, N. D., Patouret, R., Roques, B. P., & Llorens‐Cortés, C. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0125-y · Cited by 59
Meems, L. M. G., & Burnett, J. C. J. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.10.001 · Cited by 57
Self-citationTóth, A. D., Turu, G., Hunyady, L., & Balla, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.02.003 · Cited by 57
Structure of human Endothelin-converting Enzyme I Complexed with Phosphoramidon
Schulz, H., Dale, G. E., Karimi‐Nejad, Y., & Oefner, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.052 · Cited by 55
Papinska, A., Soto, M., Meeks, C. J., & Rodgers, K. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.026 · Cited by 55
Kröger, W. L., Douglas, R. G., O’Neill, H. G., Dive, V., & Sturrock, E. D. (2009) · Biochemistry · doi:10.1021/bi9011226 · Cited by 54
Self-citationAngiotensinogen and Megalin Interactions Contribute to Atherosclerosis—Brief Report
Ye, F., Ya, W., Wu, C., Howatt, D. A., Wu, C.-H., Balakrishnan, A., Mullick, A. E., Graham, M. J., Danser, A. H. J., Wang, J., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311817 · Cited by 54
Self-citationAngiotensin-Converting Enzyme Inhibitors and Angioedema
Weber, M. A., & Messerli, F. H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111393 · Cited by 53
Srivastava, P. K., Claggett, B. L., Solomon, S. D., McMurray, J. J. V., Packer, M., Zile, M. R., Desai, A. S., Rouleau, J. L., Swedberg, K. B., & Fonarow, G. C. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3957 · Cited by 53
Bader, M., Alenina, N. V., Young, D., Santos, R. A. S., & Touyz, R. M. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10918 · Cited by 52
Self-citationMolecular evidence of tissue renin-angiotensin systems: A focus on the brain
Sakai, K., & Sigmund, C. D. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0088-y · Cited by 51
Douglas, R. G., Sharma, R. K., Masuyer, G., Lubbe, L., Zamora, I., Acharya, K. R., Chibale, K., & Sturrock, E. D. (2013) · Clinical Science · doi:10.1042/cs20130403 · Cited by 51
Self-citationOlearczyk, J., Gao, S., Eybye, M. E., Yendluri, S., Andrews, L. E., Bartz, S. R., Cully, D. F., & Tadin‐Strapps, M. (2013) · Hypertension Research · doi:10.1038/hr.2013.155 · Cited by 50
Komers, R., Gipson, D. S., Nelson, P., Adler, S. G., Srivastava, T., Derebail, V. K., Meyers, K. E. C., Pérgola, P. E., MacNally, M. E., Hunt, J. L., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.02.019 · Cited by 50
Roksnoer, L. C. W., van Veghel, R., VRIES, R. D., Garrelds, I. M., Bhaggoe, U. M., Friesema, E. C. H., Leijten, F. P. J., Poglitsch, M., Domenig, O., Groningen, M. C. C., et al. (2015) · Kidney International · doi:10.1038/ki.2015.107 · Cited by 49
Self-citationRegulation of Angiotensin II Type 2 Receptor Gene by the Protein Kinase C–Calcium Pathway
Kijima, K., Matsubara, H., Murasawa, S., Maruyama, K., Ohkubo, N., Mori, Y., & Inada, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.529 · Cited by 49
Angioprotectin: an angiotensin II‐like peptide causing vasodilatory effects
Jankowski, V., Tölle, M., Santos, R. A. S., Günthner, T., Krause, E., Beyermann, M., Welker, P., Bäder, M., Pinheiro, S. V. B., Sampaio, W. O., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-185470 · Cited by 48
Atypical signaling and functional desensitization response of MAS receptor to peptide ligands
Tirupula, K. C., Desnoyer, R., Speth, R. C., & Karnik, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103520 · Cited by 47
Rozenfeld, R., Iturrioz, X., Okada, M., Maigret, B., & Llorens‐Cortés, C. (2003) · Biochemistry · doi:10.1021/bi034358u · Cited by 47
Recent clinical trials with omapatrilat: New developments
Zanchi, A., Maillard, M. P., & Burnier, M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0045-6 · Cited by 47
Structural Insights into Central Hypertension Regulation by Human Aminopeptidase A
Yang, Y., Liu, C., Lin, Y.-L., & Li, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.494955 · Cited by 47
Multiple Ascending Dose Study With the New Renin Inhibitor VTP-27999
Balcarek, J. M., Pessôa, B. S., Bryson, C., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02893 · Cited by 47
Fattah, C., Nather, K., McCarroll, C. S., Hortigon-Vinagre, M. P., Zamora, V., Flores‐Muñoz, M., McArthur, L., Zentilin, L., Giacca, M., Touyz, R. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.946 · Cited by 47
Self-citationSavergnini, S. Q., Ianzer, D. A., Carvalho, M. B. L., Ferreira, A. J., Silva, G. A. B., Marques, F. D., Peluso, A. A., Beiman, M., Cojocaru, G., Cohen, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057757 · Cited by 46
Marc, Y., Hmazzou, R., Balavoine, F., Flahault, A., & Llorens‐Cortés, C. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001563 · Cited by 46
Azizi, M., Ezan, É., Reny, J., Wdzieczak‐Bakala, J., Gerineau, V., & Ménard, J. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.879 · Cited by 45
Zhang, T., Li, Z., Dang, H., Chen, R., Liaw, C. W., Tran, T.-A., Boatman, P. D., Connolly, D. T., & Adams, J. W. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2011 · Cited by 44
Dickstein, K., de Voogd, H. J., Mirić, M., Willenbrock, R., Mitrović, V. L., Pacher, R., & Koopman, P. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.074 · Cited by 43
Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV
Oefner, C., Pierau, S., Schulz, H., & Dale, G. E. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907036281 · Cited by 43
Rozenfeld, R., Iturrioz, X., Maigret, B., & Llorens‐Cortés, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204406200 · Cited by 43
Akif, M., Schwager, S. L. U., Anthony, C. S., Czarny, B., Beau, F., Dive, V., Sturrock, E. D., & Acharya, K. R. (2011) · Biochemical Journal · doi:10.1042/bj20102123 · Cited by 43
Self-citationRoksnoer, L. C. W., van Veghel, R., Groningen, M. C. C., VRIES, R. D., Garrelds, I. M., Bhaggoe, U. M., van Gool, J. M. G., Friesema, E. C. H., Leijten, F. P. J., Hoorn, E. J., et al. (2016) · Clinical Science · doi:10.1042/cs20160197 · Cited by 42
Self-citationInhibition of renin release from rat kidney slices by the angiotensins
Naftilan, A. J., & Oparil, S. (1978) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1978.235.1.f62 · Cited by 42
Angiotensin-(1-7) Protects against the Development of Aneurysmal Subarachnoid Hemorrhage in Mice
Shimada, K., Furukawa, H., Wada, K., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.30 · Cited by 41
Nchinda, A. T., Chibale, K., Redelinghuys, P., & Sturrock, E. D. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.004 · Cited by 40
Self-citationLombard‐Banek, C., Yu, Z., Swiercz, A. P., Marvar, P. J., & Nemes, P. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01771-9 · Cited by 40
The AT2 angiotensin receptor subtype predominates in the 18 day gestation fetal rat brain
Cook, V. I., Grove, K. L., McMenamin, K. M., Carter, M. R., Harding, J. W., & Speth, R. C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91254-x · Cited by 38
Verrilli, M. A. L., Fermepín, M. R., Carbajosa, N. A. L., Landa, S., Cerrato, B. D., García, S. I., Fernández, B. E., & Gironacci, M. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07552.x · Cited by 36
Angiotensin generation in the brain: a re-evaluation
Uijl, E., Ren, L., & Danser, A. H. J. (2018) · Clinical Science · doi:10.1042/cs20180236 · Cited by 36
Self-citationMalek, V., Sharma, N., Sankrityayan, H., & Gaikwad, A. B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.027 · Cited by 36
Stragier, B., Hristova, I., Sarre, S., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04188.x · Cited by 35
Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor
Steckelings, U. M., de Kloet, A. D., & Sumners, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.06.002 · Cited by 35
Ravichandran, K., Özkök, A., Wang, Q., Mullick, A. E., & Edelstein, C. L. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00478.2014 · Cited by 34
Angiotensin II Binding to Angiotensin I–Converting Enzyme Triggers Calcium Signaling
Guimarães, P. B., de Alvarenga, É. C., Siqueira, P. D., Paredes‐Gamero, E. J., Sabatini, R. A., Morais, R. L., Reis, R. I., dos Santos, E. L., Teixeira, L. G. D. D., Casarini, D. E., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167171 · Cited by 34
Sahli, S., Frank, B., Schweizer, W. B., Diederich, F., Blum‐Kaelin, D., Aebi, J. D., Böhm, H., Oefner, C., & Dale, G. E. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200590051 · Cited by 33
No Brain Renin–Angiotensin System
Sigmund, C. D., Diz, D. I., & Chappell, M. C. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09167 · Cited by 33
Sharp, S., Poglitsch, M., Zilla, P., Davies, N. H., & Sturrock, E. D. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314568438 · Cited by 32
Self-citationPhase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
Savage, P. D., Lovato, J. F., Brosnihan, K. B., Miller, A. A., & Petty, W. J. (2016) · Sarcoma · doi:10.1155/2016/4592768 · Cited by 32
Nawarskas, J. J., Rajan, V., & Frishman, W. H. (2001) · Heart Disease · doi:10.1097/00132580-200111000-00006 · Cited by 30
Pu, Q., Touyz, R. M., & Schiffrin, E. L. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00025 · Cited by 30
Self-citationSacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy
Yandrapalli, S., Khan, M. H., Rochlani, Y. M., & Aronow, W. S. (2018) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944718784536 · Cited by 30
Cozier, G. E., Arendse, L. B., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01309 · Cited by 30
Self-citationNorLeu 3 -Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers
Rodgers, K. E., Bolton, L. L., Verco, S. J., et al. (2015) · Advances in Wound Care · doi:10.1089/wound.2014.0609 · Cited by 29
Bur, D., Dale, G. E., & Oefner, C. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.5.337 · Cited by 29
Masuyer, G., Akif, M., Czarny, B., Beau, F., Schwager, S. L. U., Sturrock, E. D., Isaac, R. E., Dive, V., & Acharya, K. R. (2013) · FEBS Journal · doi:10.1111/febs.12660 · Cited by 28
Self-citationFienberg, S., Cozier, G. E., Acharya, K. R., Chibale, K., & Sturrock, E. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01478 · Cited by 28
Self-citationRubattu, S. D., Cotugno, M., Forte, M., Stanzione, R., Bianchi, F., Madonna, M., Marchitti, S., & Volpe, M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001762 · Cited by 28
Dual ACE/NEP inhibitors – more than playing the ACE card
Jandeleit-Dahm, K. A. M. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002018 · Cited by 26
Angiotensin-(3–7) pressor effect at the rostral ventrolateral medulla
Ferreira, P. M., Santos, R. A. S., & Campagnole‐Santos, M. J. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.031 · Cited by 26
Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide
Meems, L. M. G., Andersen, I. A., Pan, S., Harty, G. J., Chen, Y., Zheng, Y., Harders, G. E., Ichiki, T., Heublein, D. M., Iyer, S. R., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12012 · Cited by 26
Self-citationPharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans
Azizi, M., Bissery, A., Peyrard, S., Guyene, T.-T., Ozoux, M. L., FLOCH, A., & Ménard, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.011 · Cited by 25
O’Neill, H. G., Redelinghuys, P., Schwager, S. L. U., & Sturrock, E. D. (2008) · Biological Chemistry · doi:10.1515/bc.2008.131 · Cited by 25
Self-citationSulpizio, A. C., Pullen, M. A., Edwards, R. M., Louttit, J. B., West, R., & Brooks, D. P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084749 · Cited by 24
The Angiotensin-Converting-Enzyme-Induced Angioedema
Baş, M. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2016.08.011 · Cited by 24
CRRL269: a novel designer and renal-enhancing pGC-A peptide activator
Chen, Y., Harty, G. J., Huntley, B. K., Iyer, S. R., Heublein, D. M., Harders, G. E., Meems, L. M. G., Pan, S., Sangaralingham, S. J., Ichiki, T., et al. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00286.2017 · Cited by 23
Self-citationDiminazene Aceturate Is an ACE2 Activator and a Novel Antihypertensive Drug
Gjymishka, A., Kulemina, L. V., Shenoy, V., et al. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.1032.3 · Cited by 22
Simon, S. R., Black, H. R., Moser, M., & Berland, W. E. (1992) · PubMed · Cited by 22
Omapatrilat. Bristol-Myers Squibb.
Tabrizchi, R. (2001) · PubMed · Cited by 21
A Computational Approach to the Study of the Binding Mode of Dual ACE/NEP Inhibitors
Dimitropoulos, N., Papakyriakou, A., Dalkas, G. A., Sturrock, E. D., & Spyroulias, G. A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9005047 · Cited by 17
Self-citationMa, L., Li, J., Wang, G., Gong, S., Zhang, L., Li, K., Ji, X., Liu, Y., Chen, P., & Xiang, X. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2012.12.003 · Cited by 14
Johnson, A. G., Pearce, G. L., & Danoff, T. M. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002009 · Cited by 12
Angioedema Spotlight: A Closer Examination of Sacubitril/Valsartan Safety Results
Owens, R. E., & Oliphant, C. S. (2017) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2017.04.170111 · Cited by 12
PIONEERing the In-Hospital Initiation of Sacubitril–Valsartan
Jarcho, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejme1900139 · Cited by 12
AT2 receptors recruit c-Src, SHP-1 and FAK upon activation by Ang II in PND15 rat hindbrain
Seguin, L. R., Villarreal, R., & Ciuffo, G. M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.008 · Cited by 11
Distribution of a novel binding site for angiotensins II and III in mouse tissues
Rabey, F. M., Karamyan, V. T., & Speth, R. C. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.02.007 · Cited by 10
Moukarbel, G. V., & Solomon, S. D. (2008) · Current Heart Failure Reports · doi:10.1007/s11897-008-0030-0 · Cited by 3
Cited by
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Apicella, M., Campopiano, M. C., Mantuano, M., Mazoni, L., Coppelli, A., & Del Prato, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30238-2 · Cited by 903
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
Danser, A. H. J., Epstein, M., & Batlle, D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457
Self-citationHess, D. C., Eldahshan, W., & Rutkowski, E. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00818-9 · Cited by 381
Metadata
- Authors
- Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 71
- Issue
- 4
- Pages
- 539-570
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2968716215
- Cited by
- 339
- References
- 351
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.